FIELD: pharmaceutical industry.
SUBSTANCE: group of inventions relates to the pharmaceutical industry, namely to induction in a host of immune tolerance to a peptide or protein active agent. A composition inducing in a host immune tolerance to a peptide or protein active agent contains erythrocytes containing a peptide or protein active agent. A method for induction of immune tolerance to a peptide or protein active agent is also described.
EFFECT: above-described composition allows for effective induction of immune tolerance.
34 cl, 5 dwg, 17 tbl, 18 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOSTIMULATING COMBINATION FOR PREVENTION AND TREATMENT OF HEPATITIS C | 2006 |
|
RU2431499C2 |
| VACCINE COMPOSITIONS AND METHODS OF USE THEREOF | 2010 |
|
RU2600798C2 |
| ANTIGENIC COMPOSITION FOR INDUCING CYTOTOXIC T-LYMPHOCYTES RESPONSE, METHOD OF INDUCTION AND METHOD OF PATIENTS TREATMENT | 1992 |
|
RU2129439C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT NEOPLASM | 2018 |
|
RU2730984C1 |
| MICROFLUIDIZED COMPOSITION FOR INDUCTION OF SPECIFIC CYTOTOXIC T-LYMPHOCYTE IMMUNE RESPONSE AND ITS USING FOR DISEASE TREATMENT | 1995 |
|
RU2201253C2 |
| MODIFIED SUPERCOILED PROTEINS WITH IMPROVED PROPERTIES | 2013 |
|
RU2677799C2 |
| COMBINATION PREPARATION FOR INCREASING POTENCY OF VACCINE (VERSIONS) | 2008 |
|
RU2491090C2 |
| IMMUNOGENIC COMPOSITION CONTAINING SYNTHETIC PEPTIDES REPEATING SEQUENCE OF V3-LOOP OF SHELL PROTEIN GP120 HIV1 | 2017 |
|
RU2694576C2 |
| PHARMACEUTICAL COMPOSITION FOR IMMUNE DISEASE TREATMENT | 2000 |
|
RU2203682C2 |
| COMPOSITION FOR STIMULATING DENDRITIC CELL MATURATION, CONTAINING HYBRID PROTEIN RV2299C/ESAT-6 | 2017 |
|
RU2733886C2 |
